课题基金 / 基金详情

Preventing Skeletal and Cardiac Muscle Aging by Restoring Mitochondrial Function

Preventing Skeletal and Cardiac Muscle Aging by Restoring Mitochondrial Function
通过恢复线粒体功能预防骨骼肌和心肌老化
批准号:
9564597
负责人:
David J. Marcinek
金额:
$81.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2019-08-31

项目摘要

项目成果

David J. Marcinek的其他基金

相似基金

相关文献

中文摘要
翻译
通过修复线粒体防止骨骼肌和心肌老化 功能 总结 衰老伴随着缓慢进行和不可逆的结构变化和功能下降, 这些联合收割机共同导致老年人运动不耐受和虚弱。的 疗养院安置率和住院率的增加使肌肉功能随着年龄的增长而丧失, 在生活质量和社会经济成本方面,公共卫生危机日益严重。尽管如此, 很少有治疗选择来逆转老年人的骨骼或心肌退化,这在很大程度上是由于 对这些功能障碍背后的机制的理解不足。我们之前的工作 研究表明,用线粒体靶向肽SS-31治疗可改善骨骼和心脏 肌肉性能,线粒体功能,并减少氧化还原应激。这些令人惊讶的结果表明 随着年龄的增长,线粒体功能障碍是一个比以前认为的更动态的过程, 通过晚年治疗来改善健康寿命。最近的数据表明,SS-31并不作为一种 传统的抗氧化剂通过清除活性氧。相反,SS-31似乎与 线粒体心磷脂,以改善线粒体电子传递系统(ETS)的功能和减少 线粒体氧化应激我们认为,短期治疗改善ETS功能, 氧化还原和能量应激,改善老年心脏和骨骼肌的功能和应激反应。 通过长期治疗,这种改善的应激信号可以恢复线粒体和组织结构, 进一步改善肌肉的性能。该提案将定义氧化还原和能量依赖 SS-31治疗逆转心脏和骨骼肌能量功能障碍的信号传导机制 老年(目标1),以及这些变化随后使心脏和 骨骼肌结构,以提高性能(目标2)。最终目标3将测试是否减少 从中年开始治疗小鼠的线粒体氧化应激可以保持肌肉健康, 运动耐力。我们相信,心脏和骨骼肌的联合研究将提供关键的 了解他们的功能障碍如何对增强的能量学做出反应的相似性和差异 和氧化还原信号,以及两者的改善将如何联合收割机,以提高健康和锻炼 宽容最终的结果将是对这种新范式的机械基础的新见解, 肌肉健康有可能直接转化为老年人。
英文摘要
PREVENTING SKELETAL AND CARDIAC MUSCLE AGING BY RESTORING MITOCHONDRIAL FUNCTION SUMMARY Aging is accompanied by slowly progressive and irreversible structural changes and functional declines in both heart and skeletal muscle that combine to contribute to exercise intolerance and frailty in the elderly. The increased rates of nursing home placement and hospitalization make the loss of muscle function with age a growing public health crisis in terms of both quality of life and economic costs to society. Despite this, there are few treatment options to reverse either skeletal or cardiac muscle degeneration in the elderly, due in large part to the poor understanding of the mechanisms that underlie these dysfunctions. Our previous work has demonstrated that treatment with the mitochondrial targeted peptide SS-31 improves skeletal and cardiac muscle performance, mitochondrial function, and reduces redox stress. These surprising results demonstrate that mitochondrial dysfunction with age is a more dynamic process than previously thought and can be reversed by late-life treatment to improve healthspan. Recent data indicates that SS-31 does not act as a traditional antioxidant by scavenging reactive oxygen species. Instead SS-31 appears to interact with mitochondrial cardiolipin to improve mitochondrial electron transport system (ETS) function and reduce mitochondrial oxidative stress. We propose that improved ETS function with short-term treatment reduces redox and energy stress which improves function and stress response of the aged heart and skeletal muscle. With long-term treatment this improved stress signaling restores mitochondrial and tissue structure, leading to further improvements in muscle performance. This proposal will define the redox and energy dependent signaling mechanisms by which SS-31 treatment reverses cardiac and skeletal muscle energetic dysfunction at late age (Aim 1), as well as the mechanisms by which these changes subsequently rejuvenates cardiac and skeletal muscle structure to improve performance (Aim 2). The final Aim 3 will test whether reducing mitochondrial oxidative stress by treating mice beginning in middle age can preserve muscle healthspan and exercise tolerance. We believe that the combined study of both heart and skeletal muscle will provide key insights into similarities and differences in how their functional impairments respond to enhanced energetics and redox signaling and how improvements in both will combine to enhance healthspan and exercise tolerance. The end result will be new insights into the mechanistic basis of this new paradigm for improving muscle health with potential for direct translation to elderly humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Redox stress resilience in aging skeletal muscle
  • 批准号:
    10722970
  • 项目类别:
  • 资助金额:
    $48.54万
  • 财政年份:
    2023
  • 负责人:
    David J. Marcinek
  • 依托单位:
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
  • 批准号:
    10438785
  • 项目类别:
  • 资助金额:
    $13.06万
  • 财政年份:
    2018
  • 负责人:
    David J. Marcinek
  • 依托单位:
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
  • 批准号:
    9702219
  • 项目类别:
  • 资助金额:
    $13.02万
  • 财政年份:
    2018
  • 负责人:
    David J. Marcinek
  • 依托单位:
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
  • 批准号:
    10205069
  • 项目类别:
  • 资助金额:
    $13.06万
  • 财政年份:
    2018
  • 负责人:
    David J. Marcinek
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: